Bifidobacterium in the treatment of inflammatory disease
AssigneesEnterprise Ireland (Trading as Bioresearch Ireland), University College Cork, National University of Ireland
InventorsJohn Kevin Collins, Gerald Christopher O'Sullivan, Liam O'Mahony, Fergus Shanahan
Life of this patent
Estimating the term…
Abstract
A strain of Bifidobacterium isolated from resected and washed human gastrointestinal tract is significantly immunomodulatory following oral consumption in humans. The strain is useful in the prophylaxis and/or treatment of undesirable inflammatroy activity, especially gastrointestinal inflammatory activity such as inflammatory bowel disease or irritable bowel syndrome. The inflammatory activity may also be due to cancer.
Claims33
An isolated strain of Bifidobacterium NCIMB 41003.
Dependencies are inferred from the claim text.